Assessing Pharmacist Comfort in Recommending OTC Medications for Pregnant Patients
Drug Topics
DECEMBER 7, 2022
Knowledge gaps can make OTC medication recommendations for this population a challenge.
Wed.Dec 07, 2022
582 
Traditional HTAs keep diverse patients out of the conversation
PhRMA
DECEMBER 7, 2022
Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Research Praises Shingles Vaccine Efficacy
Drug Topics
DECEMBER 7, 2022
The shingles vaccine appears to confer long-term immunity, according to research.
Woman of the Week: Simcha Therapeutics’ Beatrice McQueen
PharmaVoice
DECEMBER 7, 2022
From sea sponges to cytokines, the chief operating officer’s career has come full circle as she pursues a new approach to treating cancer via the immune system.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pediatric Vaccine Education Can Improve Pharmacist Knowledge, Confidence
Drug Topics
DECEMBER 7, 2022
Not every pharmacist may feel comfortable administering vaccines to children, but education could help.
10 noteworthy pharma leadership shake-ups this year
PharmaVoice
DECEMBER 7, 2022
From GSK to Roche to Biogen, these were the most impactful executive changes at leading pharma companies in 2022.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Limits of ‘Fauci effect’: infectious disease applicants plummet, and hospitals are scrambling
STAT
DECEMBER 7, 2022
Tulane University touted “the chance to train in a unique & wonderful city.” The University of Colorado offered a GIF of clouds moving across the state’s stunning mountains. And Boston Medical Center said in its plea , “Come hang with us! We’re pretty cool.” The tweets last week came from infectious diseases fellowship programs, all scrambling for doctors after a number of their positions went unclaimed during the annual “match” process
Cost Savings Associated With Therapeutic Exchange of Stimulant Medications
Drug Topics
DECEMBER 7, 2022
Cost savings were not associated with an increase in adverse drug events.
Survey Finds Many US Adults Were Not Prepared for Severity of Current Flu Season
Pharmacy Times
DECEMBER 7, 2022
The current flu hospitalization rate is the highest observed this early in a flu season in over a decade.
As Direct-to-Consumer Companies Grow in Popularity, Their Efficacy is Questioned
Drug Topics
DECEMBER 7, 2022
Direct-to-consumer companies attract attention on social media, but are they as effective as traditional healthcare services?
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Cancer patients endure an overlooked financial burden: hospital parking fees
STAT
DECEMBER 7, 2022
For many patients, one of the most antagonizing parts of a hospital visit is paying for parking. Those parking fees aren’t just an annoyance for the sick and injured, according to a new paper in the Journal of Medical Imaging and Radiation Sciences. The charges are actually eating into their financial well-being, particularly for people who have cancer and have to make frequent visits to the hospital for treatments like radiation and chemotherapy.
Examining HPV Vaccine Uptake for Adolescents During the Pandemic
Drug Topics
DECEMBER 7, 2022
Recent research looks at how the pandemic impacted the uptake of the human papillomavirus vaccine, which has traditionally lagged behind other pediatric vaccine rates.
Is Pharmacy Right For You?
Pharmacy Is Right For Me
DECEMBER 7, 2022
With college application deadlines looming, you might wonder what the right career path can look like. Have you considered pharmacy? Pharmacy offers countless career options , with pharmacists practicing in pharmacies, health systems, labs, government agencies, corporations, and so much more! Check out our latest video and find out if pharmacy is right for you!
Out-of-Pocket Costs Impact Medication Access for Some Medicare Beneficiaries With Schizophrenia
Drug Topics
DECEMBER 7, 2022
Low-income subsidies can eliminate much of the out-of-pocket costs that patients must pay.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Some Supplements Found to Benefit Cardiovascular Health, Others May Have Negative Impact
Pharmacy Times
DECEMBER 7, 2022
Omega-3 fatty acids among the micronutrients found to provide a benefit to cardiovascular health.
Unsupported Drug Price Increases Added $805 Million in Costs
Drug Topics
DECEMBER 7, 2022
Seven of the 10 top selling drugs with high price increases lack the clinical evidence to justify those increases.
Align reimbursement to expanded role of pharmacists
Drug Store News
DECEMBER 7, 2022
The industry is moving to more value-based reimbursement with community pharmacy playing an increasingly important role.
FDA to Evaluate Zuranolone for Major Depressive Disorder, Postpartum Depression
Pharmacy Times
DECEMBER 7, 2022
Zuranolone is a rapid-acting, once-daily, 14-day oral short course therapy for adult patients with major depressive disorder and postpartum depression.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
STAT
DECEMBER 7, 2022
Touted by celebrities, raved about by TikTok users and advertised by med spas, a new class of drugs for treating diabetes and obesity has exploded in popularity for its weight-loss effects, leading to rippling shortages across several of the medications. Amid the surge in demand, Eli Lilly and pharmacies have started to tighten access to the latest of this type of drug, tirzepatide, focusing on giving it to people with type 2 diabetes, the only population it’s authorized for so far.
What FDA’s Newest Gene Therapy Approval Tells Us About Durability: How Long is Long Enough?
The FDA Law Blog
DECEMBER 7, 2022
By Mark A. Tobolowsky & James E. Valentine — On November 22, 2022, FDA approved CSL Behring’s BLA for Hemgenix (etranacogene dezaparvovec), an AAV-based gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy, have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.
Opinion: Deferral of primary care signals a troubled future for Americans’ health
STAT
DECEMBER 7, 2022
Americans may be returning to their pre-pandemic habits , but most have not returned to their primary care doctors. Primary care visits are down 10.3% on average across U.S. cities relative to pre-pandemic levels. That, combined with more people with chronic diseases like diabetes, obesity, and cancer, and accelerating health care costs as inflation soars, signal a troubled future for the health of Americans and the U.S.
Upcoding isn't solely to blame for spike in 'high-intensity' ED billing, researchers say
Fierce Healthcare
DECEMBER 7, 2022
Upcoding isn't solely to blame for spike in 'high-intensity' ED billing, researchers say. dmuoio. Wed, 12/07/2022 - 15:39.
World Genomics Evaluation in Clinical Trials Sparks Worldwide Interest
Pharmacy Times
DECEMBER 7, 2022
Breast cancer expert joined a panel to discuss aromatase inhibitors at the San Antonio Breast Cancer Symposium (SABCS) on December 6, 2022.
STAT+: Prometheus’ inflammatory bowel drug succeeds in two mid-stage trials
STAT
DECEMBER 7, 2022
An investigative medicine from Prometheus Biosciences met its goals in a pair of Phase 2 studies enrolling patients with inflammatory bowel disease, setting the stage for pivotal trials and nearly doubling the company’s stock price. In an ulcerative colitis study enrolling about 130 volunteers, Prometheus’ drug helped nearly 27% of patients reach clinical remission, defined as an absence of serious symptoms, compared to 1.5% for the placebo group, the company said.
Interim Analysis Updates Adjuvant Abemaciclib Plus Endocrine Therapy Study
Pharmacy Times
DECEMBER 7, 2022
Phase 3 monarchE trial assesses distant relapse free-survival, invasive disease-free survival, and overall survival for the treatment of HR-positive/HER2-negative-, node-positive, high-risk early breast cancer.
Sign-ups on ACA exchanges up 18% year over year to 5.5M so far
Fierce Healthcare
DECEMBER 7, 2022
Sign-ups on ACA exchanges up 18% year over year to 5.5M so far. pminemyer. Wed, 12/07/2022 - 16:11.
STAT+: FDA scolds company that raised red flags over impurities in many widely used medicines
STAT
DECEMBER 7, 2022
Two years after an independent laboratory began pushing the Food and Drug Administration to analyze various medicines for traces of carcinogens, the agency sent inspectors to the company and cited it for failing to comply with federal law. In a Dec. 5 letter , the agency wrote Valisure that its online pharmacy failed to take several basic steps to ensure that suspect or illegitimate medicines were investigated and that distributors were alerted.
Black Women With Breast Cancer Show Worse Outcomes Than Peers
Pharmacy Times
DECEMBER 7, 2022
RxPonder clinical trial results indicate that racial disparities continue to be a major health care challenge.
STAT+: In ‘landmark’ study, cell therapy exceeds expectations in melanoma patients
STAT
DECEMBER 7, 2022
When tumors like melanoma form, the immune system mobilizes for war. White blood cells called lymphocytes rush to assault the tumor — but cancer has ways of disabling the immune system. Once the immune cells penetrate the area in and around the tumor, they can be caught in chemical snares that render them inert or exhausted, so they cease working.
Loblaw to open 4 pharmacist-led health clinics in Alberta
Drug Store News
DECEMBER 7, 2022
The clinics will be located in underserviced areas of the province - Fort Saskatchewan, Brooks, Red Deer and Edson.
Bill that puts more antibiotics on market no sure thing
Fierce Healthcare
DECEMBER 7, 2022
Bill that puts more antibiotics on market no sure thing. fdiamond. Wed, 12/07/2022 - 13:39.
L’Oréal educates consumers on product environmental impact with labeling system
Drug Store News
DECEMBER 7, 2022
L’Oréal’s Product Impact Labeling gives items a ranking on a scale from A to E by considering 14 planetary impact factors.
Alzheimer’s disease biomarkers galvanise rocky drug development space
Pharmaceutical Technology
DECEMBER 7, 2022
Last week, the quest for an effective Alzheimer’s disease therapy received a notable fillip at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2022, with new data on Eisai’s disease-modifying therapy lecanemab. Alongside the discourse on what the positive study results could mean for patients, researchers are prioritising the development of more biomarkers to identify potential responders and improve patient outcomes.
Let's personalize your content